[1] Zhao MX, Zhao QH, Zheng MY, Liu T, Li Y, Wang M, et al. Effect of resting heart rate on the risk of all-cause death in Chinese patients with hypertension: analysis of the Kailuan follow-up study. BMJ Open 2020;10(3):e032699. http://dx.doi.org/10.1136/bmjopen-2019-032699CrossRef
[2] Zhang X, Zhang M, Li C, Wang LH, Wu J, Huang ZJ, et al. Associations between hypertension status and increased heart rate - China, 2015. China CDC Wkly 2020;2(40):771 − 5. http://dx.doi.org/10.46234/ccdcw2020.209CrossRef
[3] Kang E, Lee S, Ha E, Oh HJ, Ryu DR. The effects of blood pressure components on cardiovascular events in a Korean hypertensive population according to age and sex: a nationwide population-based cohort study. Medicine (Baltimore) 2019;98(33):e16676. http://dx.doi.org/10.1097/MD.0000000000016676CrossRef
[4] Sun NL, Huo Y, Huang J. The current status of heart rate in Chinese hypertensive patients. Chin J Hypertens 2015;23(10):934 − 9. http://dx.doi.org/10.16439/j.cnki.1673-7245.2015.10.013 (In Chinese). CrossRef
[5] Palatini P, Thijs L, Staessen JA, Fagard RH, Bulpitt CJ, Clement DL, et al. Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension. Arch Intern Med 2002;162(20):2313 − 21. http://dx.doi.org/10.1001/archinte.162.20.2313CrossRef
[6] Santosa A, Zhang Y, Weinehall L, Zhao GM, Wang N, Zhao Q, et al. Gender differences and determinants of prevalence, awareness, treatment and control of hypertension among adults in China and Sweden. BMC Public Health 2020;20(1):1763. http://dx.doi.org/10.1186/s12889-020-09862-4CrossRef
[7] Gillis EE, Sullivan JC. Sex differences in hypertension: recent advances. Hypertension 2016;68(6):1322 − 7. http://dx.doi.org/10.1161/HYPERTENSIONAHA.116.06602CrossRef
[8] Esler M, Lambert G, Esler D, Ika Sari C, Guo L, Jennings G. Evaluation of elevated heart rate as a sympathetic nervous system biomarker in essential hypertension. J Hypertens 2020;38(8):1488 − 95. http://dx.doi.org/10.1097/HJH.0000000000002407CrossRef
[9] Di Giosia P, Giorgini P, Stamerra CA, Petrarca M, Ferri C, Sahebkar A. Gender differences in epidemiology, pathophysiology, and treatment of hypertension. Curr Atheroscler Rep 2018;20(3):13. http://dx.doi.org/10.1007/s11883-018-0716-zCrossRef
[10] Kim H, Lee S, Ha E, Kwon SH, Jeon JS, Noh H, et al. Age and sex specific target of blood pressure for the prevention of cardiovascular event among the treatment naive hypertensive patients. Sci Rep 2020;10(1):21538. http://dx.doi.org/10.1038/s41598-020-78641-3CrossRef